Staphylococcus aureus is a metabolically versatile pathogen that colonizes nearly all organs of 24 the human body. A detailed and comprehensive knowledge of staphylococcal metabolism is 25 essential to understanding its pathogenesis. To this end, we have reconstructed and 26 experimentally validated an updated and enhanced genome-scale metabolic model of S. aureus 27 USA300_FPR3757. The model combined genome annotation data, reaction stoichiometry, and 28 regulation information from biochemical databases and previous strain-specific models. 29 Reactions in the model were checked and fixed to ensure chemical balance and thermodynamic 30 consistency. To further refine the model, growth assessment of 1920 non-essential mutants from 31 the Nebraska Transposon Mutant Library was performed and metabolite excretion profiles of 32 important mutants in carbon and nitrogen metabolism were determined. The growth and no-33 growth inconsistencies between the model predictions and in vivo essentiality data were resolved 34 using extensive manual curation based on optimization-based reconciliation algorithms. Upon 35 intensive curation and refinements, the model contains 840 metabolic genes, 1442 metabolites, 36 and 1566 reactions including transport and exchange reactions. To improve the accuracy and 37 predictability of the model to environmental changes, condition-specific regulation information 38 curated from the existing knowledgebase was incorporated. These critical additions improved the 39 model performance significantly in capturing gene essentiality, substrate utilization, and 40 metabolite production capabilities and increased the ability to generate model-based discoveries 41 of therapeutic significance. Use of this highly curated model will enhance the functional utility 42 of omics data and, therefore, serve as a resource to support future investigations of S. aureus and 43 to augment staphylococcal research worldwide. 44 45 3 Keywords: Staphylococcus aureus, genome-scale metabolic model 46 109 Results 110 Reconstruction of an updated model of S. aureus metabolism 111 Preliminary reconstruction utilizing the existing knowledge base 112 A collection of 1511 metabolic reactions obtained from a consensus of recently published strain-113 specific models 19,21 was assembled into a preliminary model of S. aureus. Out of 842 genes in 114 6 the latest strain-specific USA300_FPR3757_uid58555 model by Bosi et al. 19 , 109 did not have 115 any reactions associated with them, which were not included in our model at this stage. Checking 116 reactions from the S. aureus N315 model iSB619 20 against the annotations of strain 117 USA300_FPR3757 in the KEGG database 39 resulted in the inclusion of seven unique reactions to 118 the preliminary model. In addition, every metabolic function in the model was verified for 119 correct gene annotations in the NCBI, KEGG, and UniProt databases and published 120 resources 19,39-42 to amend the model with 38 metabolic reactions and annotate 75 additional 121 reactions with correct Gene-Protein-Reaction (GPR) rules. 122 123 These amendments resulted in a preliminary model that contained 833 metabolic genes 124 catalyzing 1556 reactions involving 1440 metabolites. This model included reactions for central 125 carbon metabolism, secondary biosynthesis pathway, energy and cofactor metabolism, lipid 126 synthesis, elongation and degradation, nucleotide metabolism, amino acid biosynthesis and 127 degradation. All the existing metabolic reconstructions of S. aureus 19,20,22 , including the most 128 recently published model 21 , used a biomass equation similar to the closely-related organisms 129
Introduction

47
S. aureus is a versatile human pathogen that has emerged as one of the most successful infectious 48 agents of recent times, affecting approximately 20% of the world's population 1-3 . The incidence 49 of methicillin resistance at low fitness cost has significantly contributed to the rise in 50 community-associated methicillin resistant S. aureus (CA-MRSA) infections, which 51 significantly limit therapeutic options and increase rates of mortality, morbidity and costs 52 associated with its treatment 1, 4, 5 . This threat to human health has resulted in a steady interest and 53 focus on understanding how staphylococcal metabolism relates to antibiotic resistance and 54 pathogenesis. A number of studies have attempted to explore the metabolic aspects of 55 antimicrobial functionality of MRSA, including nitric oxide metabolism, oxidative stress, carbon 56 overflow metabolism, redox imbalance etc. [6] [7] [8] [9] [10] [11] . However, a complete mechanistic understanding 57 of staphylococcal metabolism is still missing, making the identification of systematic therapeutic 58 targets challenging. 59
60
The increase in knowledge of macromolecular structures, availability of numerous biochemical 61 database resources, advances in high-throughput genome sequencing, and increase in 62 computational efficiency have accelerated the use of in silico methods for metabolic model 63 development and analysis, strain design, therapeutic target discovery, and drug development 12-17 . 64 There have been a number of attempts to reconstruct the metabolism of multiple strains of S. 65 aureus using semi-automated methods [18] [19] [20] [21] [22] . However, the absence of organism-specific 66 metabolic functions and the inclusion of genes without any specified metabolic functions still 67 limit the utility of these models. These models need to be continually refined and updated to 68 4 accurately predict biological phenotypes by addressing these issues as well as by reducing 69 metabolic network gaps, elemental imbalance, and missing physiological information. Since the 70 predictive genome-scale metabolic models of several microorganisms were useful in performing 71 in silico gene essentiality and synthetic lethality analyses and yielded promising results in 72 pinpointing metabolic bottlenecks and potential drug targets 14, [23] [24] [25] [26] , the potential for accurately 73 modeling S. aureus metabolism is immense. To this end, Seif et al recently developed an updated 74 genome-scale model of S. aureus strain JE2, incorporated 3D protein structures, evaluated gene 75 essentiality predictions against experimental physiological data, and assessed flux distributions 76 in different media types 21 . Although their model was informed by multilevel omics data and a 77 significant step toward deciphering the metabolic differences of this organism under different 78 environmental conditions, it could further be improved by incorporating the latest annotation 79 information, reducing the inconsistency in gene essentiality predictions, and removing spurious 80 metabolic functionalities. 81 82 Several other studies have been dedicated to elucidating the metabolic aspects of staphylococcal 83 virulence and to pinpoint the key metabolic "hubs" in carbon and nitrogen metabolism 11,27-32 . 84 However, a majority of these studies were focused on specific segments of staphylococcal 85 metabolism and overlooked a system-wide inter-dependence that drives fitness, metabolic 86 robustness, virulence, and antimicrobial resistance. Hence, a holistic approach of in silico 87 genome-scale modeling and in vivo experimentation is crucial for gaining an improved 88 mechanistic understanding of staphylococcal metabolism and, thereby, facilitating the 89 development of novel therapeutic strategies to combat staphylococcal infections. 90 91 5
In this study, a comprehensive genome-scale metabolic model of S. aureus USA300_FPR3757 92 was reconstructed using annotation information from biochemical databases 33,34 and previous 93 strain-specific models 19, 20, 34 and validated through experimental observations and published  94 phenotypic data. The model underwent extensive manual curation to ensure chemical and charge 95 balance, thermodynamic consistency, and biomass precursors production. To test and inform the 96 model, the fitness level of 1920 mutants from Nebraska Transposon Mutant Library (NTML) 35 97 was assessed through an elaborate growth experiment and the metabolite excretion profiles of 98 eight important mutants distributed across several pathways of the carbon and nitrogen 99 metabolism were measured. The growth phenotyping results of the NTML mutants were utilized 100 via GrowMatch procedure 36 to reconcile in silico vs. in vivo growth inconsistencies. Upon 101 incorporating conditional regulations in the model gleaned from existing 'omics' datasets 30,37,38 , 102 the predictive capability of the model in terms of gene essentiality and metabolite excretions in 103 different environmental conditions was further improved. Furthermore, the growth predictions 104 from the model on 69 different carbon sources were validated against existing growth 105 experiment 21 . Overall, this model is extensively tested by multiple available and newly-106 developed experimental datasets on staphylococcal metabolism and subsequently refined to pave 107 a way forward to advance system-wide analysis of fitness and virulence. 108 7 The preliminary reconstruction underwent extensive manual curation steps as outlined in the 137 methods section. In total, 197 reactions (excluding the biomass reaction, demand, sink, and 138 exchange reactions) were found to be imbalanced in terms of proton, carbon, nitrogen, oxygen or 139 sulfur. Most of these reactions (i.e.,182 reactions) were fixed for proton imbalance and four 140 reactions were fixed for imbalance in other elements (see Supplementary Table 2 for details).  141 Nonetheless, a few mass-and charge-imbalanced reactions remained in the model, primarily due 142 to the presence of macromolecules with unspecified "R"-groups and gaps in knowledge about 143 correct reaction mechanisms. These remaining reaction imbalances are common in published 144 genome-scale metabolic models 46 and given that the overall stoichiometry of the reactions 145 involving these macromolecules is correct, these imbalances do not significantly affect the 146 performance of the model. 147
148
In addition to charge and elemental imbalances, the preliminary model had 291 reaction fluxes 149 unnecessarily hitting the upper or lower bounds during a Flux Variability Analysis (FVA) when 150 no nutrients were provided (see Methods section). Also, the inconsistent dissipation of ATP, 151 which was persistent in earlier models 19, 21 , also existed in the preliminary reconstruction. These 152 two phenomena are observed when the reaction network contains thermodynamically infeasible 153 cycles (as defined in the Methods section) 47 . To resolve these cycles, 27 reactions were made 154 irreversible and two reactions were reversed in directionality based on available thermodynamic 155 information and literature evidence (details in Supplementary Table 3 ). Furthermore, 66 156 reactions were turned off either due to their improper annotations or to remove lumped or 157 duplicate reactions from the model. For example, the irreversible duplicates for several reactions 158 including acetolactate synthase, aconitase, phosphoribosylaminoimidazole carboxylase, alcohol-159 8 NAD oxidoreductase, arginine deiminase, D-ribitol-5-phosphate NAD 2-oxidoreductase, 160 glycerate dehydrogenase, methionine synthase, and ribokinase were removed. Also, based on 161 available cofactor specificity information, reactions such as cytidine kinase (GTP), glycerol-3-162 phosphate dehydrogenase (NAD), guanylate kinase (GMP:dATP), and homoserine 163 dehydrogenase (NADH) were turned off to ensure correct cofactor usage in these reactions. 164
Reactions involved in polyamine synthesis and degradation were removed due to the lack of 165 convincing evidence of polyamine functionality in S. aureus USA300_FPR3757 28,45 . After these 166 manual curation steps, the number of unbounded reactions (reaction fluxes hitting either the 167 upper or the lower bound without any nutrient uptake) was reduced to seven. The annotation of 168 S. aureus USA300_FPR3757 genome in the KEGG database was next used to bridge several 169 network gaps in the model. At this stage, the model contained 553 blocked reactions compared to 170 784 in the preliminary reconstruction. While this was a significant improvement, the model still 171 contained a greater number of blocked reactions than other similar-sized models 21 . The blocked 172 reactions were not removed at the current stage because they contained proper gene annotation 173 information but either their terminal dead-end metabolite was beyond the scope of the model or 174 no convincing evidence (e.g., high-score annotations) for filling the gap was available. A 175 detailed list of the corrections and additions/removals made is given in Supplementary Table 3 . 176
The model reconstruction process, pathway distribution, and comparative model statistics are 177 shown in Figure 1 Identifying essential genes from existing knowledgebase 185
We next evaluated the growth profiles of the viable S. aureus mutants from the NTML 35 . The 186 variation of wild-type growth among the 384-well plates in the experiment was statistically 187 insignificant based on z-score (see Supplementary Table 4 for detailed calculations). Out of the 188 1920 mutants studied, there were 154 genes whose mutations reduced growth by 10% relative to 189 the wild-type strain and 21 mutations reduced the growth between 30% and 80% compared to 190 the wild-type value. Out of all the genes from the NTML library, 41 genes were reported to be 191 essential in other recent studies 18,48-52 , whereas only 11 of them showed any significant growth 192 inhibition (more than a standard deviation from the average wild-type growth rate) in the current 193 study (see Supplementary Table 4 for details). Therefore, the set of essential genes was a 194 consensus of multiple literature sources 18,48-52 and our current experimental study (see Methods 195 and Supplementary Text S1 for details). Briefly, transposon mutagenesis followed by growth 196 experiments by Valentino et al. 49 and Chadhuri et al. 51 identified 426 and 351 essential genes, 197 respectively. Since the disagreement regarding gene essentiality was persistent among these 198 datasets, the common essential gene (comprsing 319 genes) set from these two transposon 199 mutagenesis experiment was considered to be essential, which also agreed with multiple 200 previous growth experiments 18,50,52 . Later, Santiago et. al 48 demonstrated that gene essentiality 201 derived from transposon libraries can be affected by the high temperatures used to remove the 202 plasmid delivery vehicle and also by the polar effect in disrupting expression of essential genes 203 in the vicinity of a non-essential gene. Therefore, following their results, these false positive 204 genes (30 in total) were excluded from the essential gene list. Finally, for the modeling purpose, 205 only the 167 metabolic genes (excluding non-metabolic genes) present in the model were 206 10 considered to be the core set of essential genes in the current study (see Supplementary Table 5  207 for the full list of the essential genes). 208 209
Model refinement to reconcile growth and no-growth inconsistencies 210
Comparison of essential and non-essential genes between the experimental (in vivo) and model-211 based (in silico) gene essentiality analysis (see Methods section for details) show that there exists 212 a significant mismatch between these two sets of results (Figure 2a ). Correct model predictions 213 for non-essential and essential genes are denoted by GG and NGNG, while wrong model 214 predictions for non-essential and essential genes are denoted by NGG and GNG, respectively in 215 which the first of the two terms ("G" or "NG") corresponds to in silico and the second term 216 refers to in vivo observations. An optimization-based procedure called Growmatch was used to 217 reconcile the GNG inconsistencies by suppressing spurious functionalities and the NGG 218 inconsistencies by adding miss-annotated functionalities to the model 36 . The overall impact of 219 applying Growmatch is shown in Figure 2b . The specificity increased from 52% to 60.5%, the 220 sensitivity increased from 87% to 89%, and the false viability rate decreased from 48% to 39.5%. 221
To resolve the NGG inconsistencies, metabolic functions were added from the E. coli iAF1260 44 222 and B. subtilis 43 metabolic models as well as the Modelseed database 34 . A total of five reactions 223
were added to the model and three reactions were allowed to go in the reverse direction based on 224 literature evidence or thermodynamic information (detailed procedure outlined in Supplementary 225 Information 1), which reduced the number of NGGs by 12. Model predictions of essential genes 226 were further improved upon the removal of spurious metabolic functions. To this end, six 227 reactions that did not have either any gene associated with them (orphan reactions) or proper 228 gene annotation, were removed from the model, resulting in an 18% reduction in GNGs. 81 of 229 11 the GrowMatch predicted resolution strategies were not accepted because they resulted in 230 conflicts with correct growth (GG) and no-growth (NGNG) predictions in the model. The details 231 of the GrowMatch results are presented in Supplementary Table 5 . Two example case studies for 232 NGG and GNG inconsistency reconciliation process by GrowMatch are presented in the next 233 section. 234 Case studies for reconciliation of NGG and GNG inconsistencies 242
The deletion of aspartate transaminase appeared to be lethal by the model prediction, whereas it 243 was non-essential in vivo, making it an NGG gene (the solid blue line in Figure 2c ). The addition 244 of L-aspartase (dashed blue line in Figure 2c ) rescues the growth of an aspartate transaminase 245 deletion mutant by creating another route to generate L-aspartate, which was characterized other 246 closely related bacteria including E. coli and B. subtilis [53] [54] [55] . On the other hand, the Pentose 247 Phosphate Pathway contained a GNG inconsistency, in which there were erroneous metabolic 248 functions present in the model (Figure 2d ). For example, glucose-6-phosphate isomerase and 249 ribulose phosphate 3 epimerase are both essential genes (green highlighted genes in Figure 2d The essentiality predictions for 29 amino acid catabolic pathway genes in the model was 267 validated against the mutant growth phenotypes evaluated in a previous study 29 . The mutants 268 were grown in a chemically defined medium (CDM) supplemented with 18 amino acids but 269 lacking glucose. It was found that 11 of the mutations did not cause any growth defect, while 11 270 mutations caused intermediate growth defect and seven mutations were lethal. It was found that 271 the model failed to recapitulate growth phenotype for nine (ald1/ald2-aldehyde dehydrogenase, 272 aspA-aspartate aminotransferase, gltA-citrate synthase, sdhA-succinate dehydrogenase, 273 sdaAA/sdaAB-serine dehydratase, ansA-asparaginase, arcA1/arcA2-arginine deiminase, and 274 rocF-arginase) out of the 29 mutants, which warranted further investigation and refinements in 275 the relevant pathways in the model. The complete growth suppression of the pckA mutant was 276 13 not observed in the model because multiple other routes for the chemical conversion between 277 phosphoenol pyruvate and oxaloacetate i.e., enolase (eno), phosphoshikimate 1-278 carboxyvinyltransferase (aroA) etc. are present in the model. The deletion of ackA gene also did 279 not show severe growth inhibition because acetate could be generated via several routes in 280 addition to the Pta-AckA pathway, specially pdhABCD, aldA, or adhE. The gudB mutant did not 281 appear to be an essential gene in the model simulation because other genes including D-alanine 282 transaminase (dat) and aspartate transaminase (aspA) could convert glutamate to alpha-283 ketoglutarate. However, it has been previously shown that the uptake of L-alanine in bacteria can 284 be kinetically limited 56 . Hence, a tighter constraint on alanine uptake was imposed in the model, 285
which resulted in a correct prediction of the essentiality of the gudB gene. The essentiality of 286 sucC and sucA genes was ensured in the model by rectifying the alternate pathway consisting of 287 succinyldiaminopimelate transaminase (dapE) and tetrahydrodipicolinate succinylase (dapD). In 288 addition to that, the TCA cycle reactions converting citrate to succinyl-CoA were constrained to 289 allow flux towards the forward direction only. Two of the gaps in the histidine transport pathway 290 and proline catabolism were filled during the refinement process to allow for utilization of these 291 alternate carbon sources in the absence of glucose. Ornithine-putrescine antiport, lactate 292 dehydrogenase (ferricytochrome), malic enzyme (NADP), succinyldiaminopimelate 293 transaminase etc. were removed from the model due to the lack of evidence of these 294 functionalities in S. aureus. Upon these refinements, the model was able to correctly predict 24 295 (out of 29) of the mutant phenotypes. The model refinements in the central metabolic pathway in 296 terms of correction of reaction directionality, additions, and deletions are shown in Figure 3 . Metabolite excretion profiles of mutants with altered carbon metabolism 302
In addition to the model refinements mentioned in the preceding section, we determined the 303 metabolite excretion profiles of eight mutants during exponential growth (Figure 4 and 304 Supplementary Table 6 ) and compared them to the model predicted excretion patterns in both 305 CDM and CDMG (CDM media with added glucose) media. The mutants considered were pyc 306 (pyruvate carboxylase), citZ (citrate synthase), sucA (2-oxoglutarate dehydrogenase), ackA 307 (acetate kinase), gudB (glutamate dehydrogenase), ndhA (NADH dehydrogenase), menD 308 (menaquinone biosynthesis protein) and atpA (a subunit of ATPase). These mutants were 309 selected for their potential in identifying carbon and nitrogen redirection pathways as they affect 310 important metabolic pathways associated with central metabolism including glycolysis, TCA 311 cycle, gluconeogenesis, Electron Transport Chain (ETC), cellular redox potential and overflow 312 metabolism. In general, supplementation of glucose (CDMG) as the primary carbon source 313 resulted in the excretion of acetate as the major byproduct in all mutants (Figure 4) . In CDM, the 314 ackA, gudB, ndhA, atpA, and menD mutants displayed delayed growth kinetics (data not shown). 315
Although acetate remained a major byproduct of strains in CDM, this was due to amino acid 316 deamination as evidenced by ammonia excretion (Figure 4 ). As carbon flux through the ATP-317 generating Pta-AckA pathway is significant in S. aureus, we also observed the excretion of 318 pyruvate and redirection of carbon flux towards acetoin and α -ketoglutarate in the ackA mutant 319 ( Figure 4 ). Mutations that affected respiration (ndhA and menD) of S. aureus resulted in 320 increased levels of lactate production to maintain cellular redox when grown in CDMG (Figure  321 Supplementary Table 7 . A major 332 regulatory system that was incorporated in the model was the carbon catabolite repression, which 333 is a well-studied global regulatory process in low-GC Gram-positive bacteria in the presence of a 334 preferred carbon source that induces the repression of genes involved in the metabolism of 335 alternative carbon sources 30 . CcpA, the carbon catabolite control protein, is known to repress 336 genes involved in the utilization of amino acids as alternative carbon sources in the presence of 337 glucose 38 . In addition, SrrAB and Rex-dependent transcriptional regulation are prominent driving 338 forces of metabolic flux through respiratory metabolism that was integrated into the model. 339
Furthermore, mutant-specific repression of respiration, histidine and ornithine metabolism, and 340 pyruvate metabolism were imposed on the model for the menD mutant. For each of the mutants, 341 the incorporation of these regulations resulted in a deviation of the metabolic flux space (defined 342 as the range between the minimum and maximum flux through reactions, see Methods section 343 for details) compared to the wild type, as illustrated in Figure 5 . was observed, acetate excretion was decreased in the ackA mutant compared to the wild-type 353 strain, due to inactivation of the Pta-AckA pathway. On the other hand, the sucA mutant in CDM 354 media showed increased production of acetate due to increased flux space in the Pta-AckA 355 pathway (see Figure 5 ). The Pta-AckA pathway is known to supply a major portion of the ATP 356 required for growth 27 . With the atpA gene turned off in the model Pta-AckA pathway supplied 357 most of the ATP demand, which increased the acetate production in CDMG media for the atpA 358 mutant compared to the wild-type. However, in CDM media, the model could not sustain the 359 ATP maintenance demand of the atpA mutant and therefore, did not produce any acetate. In 360 CDMG media, the model-predicted excretion profile for urea in all of the mutants matched with 361 the experimental observations. In CDM media, the model predictions of higher urea excretion 362 compared to the wild-type strain agreed with the experimental observations for pyc, gudB, ndhA, 363 and menD mutants. Similar to the experimental results, excretion of ammonia was predicted by 364 the model in all mutants when glucose was absent (CDM media). These correct predictions can 365 be attributed to the deamination of the amino acids consumed in CDM media when the cell 366 adapts to amino acids due to CcpA-mediated control of amino acid metabolism. the flux space for lactate dehydrogenase (LDH) widened, which allowed for more lactate 376 excretion in the CDMG media. In the menD mutant, mutant-specific regulation information from 377
Kohler et al 37 resulted in the correct prediction of lactate and acetate excretion. A mutation in 378 menD or any other gene in the menaquinone biosynthesis pathway resulted in weakened 379 respiratory functions and emulated anaerobic condition in the cell, which in turn caused a 380 significant increase in the excretion of lactate in CDMG media. However, although the 381 respiratory functions were downregulated in CDM media (apparent from the shrinkage of the 382 flux space), there was no change in acetate excretion compared to the wild type strain. In CDMG 383 media, the conversion of pyruvate to oxaloacetate by pyruvate carboxylase was not active in the 384 wild type model. A small amount of phosphoenol pyruvate was converted to oxaloacetate (via 385 PEPC), which was then used in the conversion of glutamate to aspartate. However, since no 386 convincing evidence for phosphoenol pyruvate carboxylase was found in S. aureus, PEPC was 387 removed. This refinement shifted carbon flux through pyruvate carboxylase in the wild type 388 model and also resulted in correct model prediction of acetate excretion in CDMG media when 389 pyruvate carboxylase was turned off. 390 391 While the incorporation of the CcpA, Rex and SrrAB regulations was critical in capturing the 392 physiological behavior of S. aureus by the model, it should be noted that there are still gaps in 393 our knowledge about the quantitative repression effect on the reaction fluxes in the presence of 394 these regulators. For example, in CDMG media, ammonia production was not predicted in the 395 menD, atpA, and sucA mutants by the model, which was observed experimentally. However, 396 upon further investigation, it was observed that relaxing the repressions of reaction fluxs that 397
were imposed on the model due to CcpA, Rex, and SrrAB regulators, the discrepancies were 398 removed. In CDMG media, the citZ mutant correctly predicted the excretion pattern of acetate, 399 because with the reduced flux space for the TCA cycle reactions, more carbon could be directed 400 to the Pta-AckA pathway. However, in the CDM media, when amino acids were the primary 401 source of carbon, deletion of the citZ gene did not have any effect on the model predicted flux 402 space in the Pta-AckA pathway. In the pyc mutant, carbon flux to oxaloacetate was directed 403 through malate dehydrogenase (MDH3) in the model, which involved the consumption of 404 menaquinone produced by cytochrome oxidase BD. When the pyc gene was active, the same 405 conversion was mediated through malic enzyme (ME1) and the pyruvate carboxylase (PC). 406
However, since the model could accommodate the metabolic shift in both the wild-type and pyc 407 mutant, no change in the excretion rate of acetate or lactate was observed. Also, while the CcpA 408 repression was active, the deletion of the gudB gene in the model did not have any effect on the 409 lactate and acetate excretion profiles in CDMG media. In CDM media, the model prediction for 410 no lactate production was consistent with experimental observations but still no effect was 411 observed on acetate production. Also, the model predicted a lower urea production rate in the 412 atpA mutant compared to the wild-type strain, while it was higher in our experiments. Also, no 413 urea excretion was observed in the citZ mutant in our experiments but model predicted urea 414 19 excretion at the same rate as the wild-type strain. The reason for these inconsistencies could be 415 the lack of a complete understanding of the regulatory processes that affects the relationship 416 between amino acid catabolism, urea cycle, TCA cycle and pyruvate metabolism. These 417 inconsistencies warrant further investigation into CcpA-mediated metabolic control. 418 419
Estimation of carbon catabolism capacity of the model 420
In order to further test the accuracy of the model, the growth predictive capability of the model 421 was validated against a recent study of carbon source utilization by S. aureus strain USA300-422 TCH1516 by Seif et al. 21 . Out of the 69 carbon sources tested, the authors observed growth on 53 423 metabolites and no growth on 16 metabolites in their BIOLOG experiment. Our model correctly 424 predicted growth on 41 and no-growth on 12 of the carbon sources, and falsely predicted growth 425 on four and no-growth on 12 carbon sources (see Supplementary Table 8 for details). In 426 comparison, iYS854 correctly predicted growth on 42 and no-growth on 5 of the carbon sources, 427 and falsely predicted growth on 11 and no-growth on 11 carbon sources. Overall, our model 428 achieved a specificity of 75%, a precision of 91%, and an accuracy of 77%, which in general are 429 either at par with or better than previously developed models 21 and further demonstrates the 430 improved predictive capability of this new model. 431
432
Discussions 433
In the current study, an updated and comprehensive genome-scale metabolic model of the 434 methicillin-resistant human pathogen S. aureus USA300_FPR3757 was reconstructed from the 435 previous strain specific models [19] [20] [21] predictions of other studies 18, [48] [49] [50] [51] [52] . Therefore, the true set of essential genes required further 452 scrutiny, which is why, as a conservative estimate, we used a consensus set of essential genes by 453 utilizing the existing knowledge base and our own experimental findings (more details in 454 Supplementary Information 1). Moreover, several mutants compromised in growth could be 455 found in all the different methods, which did not appear to inhibit growth significantly during 456 model simulations. Instead, the model either predicted growth at full capacity or became 457 completely growth-inhibited. This phenomenon suggests that the model has degeneracy in the 458 flux space that may compensate for lost functionality by redirecting or shifting metabolic fluxes. 459
This issue calls for a more rigorous study of the regulatory influences and necessitates further 460 21 future studies in enzymatic efficiencies and kinetics associated with important metabolic 461 pathways. 462
463
The growth phenotyping studies of mutations in the amino acid catabolic pathway 29 revealed 464 shifts in S. aureus metabolism in the absence of a preferred carbon source and elucidated the 465 extent of carbon catabolic repression, which allowed us to make necessary amendments to the 466 model in terms of correction of reaction directionality, removal and addition of reactions, and 467 specifying cofactor utilization across the central metabolic pathway (see Figure 3 for details). 468
The change in media components (CDM vs. CDMG) resulted in a significant redistribution of 469 metabolic flux in the model, as was evident from the shifts in flux space for different mutants in 470 the carbon and nitrogen metabolic pathways. These shifts predicted how inactivation and/or 471 repression of TCA cycle, respiration, electron transport and ATP generation could impact the 472 cellular redox balance, metabolite production, and fitness. While the model predictions for 473 acetate and lactate production in the ackA and sucA mutants and ammonia and urea production in 474 ackA, pyc, gudB, ndhA, and menD mutants matched with experimental results, other mutants 475 showed deviations in their metabolite excretion behavior. The prediction capability of the model 476 was improved upon the addition of regulatory information obtained from existing 'omics' 477 datasets 30, 37, 38 . For example, incorporation of Rex and SrrAB regulation caused repression on 478 pyruvate metabolism and alcohol dehydrogenase pathways, which resulted in correct predictions 479 of acetate excretion by the ndhA mutant in both CDM and CDMG media, and by the citZ and pyc 480 mutants in CDMG media. Moreover, imposing mutant-specific repressions was critical to 481 achieving predictive results for the acetate and lactate excretion in the menD mutant and 482 ammonia and urea excretion in the atpA mutant. However, the current knowledge of the 483 22 regulatory landscape in S. aureus is not sufficient to explain some of the inconsistent metabolite 484 production trends in the remainder of the mutants, thus, warranting the need for further 485 investigation. 486 487 S. aureus remains a significant threat to human health, which drives a growing number of studies 488 towards understanding how staphylococcal metabolism relates to antibiotic resistance and 489 pathogenesis. Very few studies have addressed these interrelationships from a systems biology 490 perspective, which requires a predictive in silico metabolic model capable of capturing the 491 biochemical features of the pathogen. This work addresses these gaps through the development 492 of a detailed metabolic model informed not only from existing resources, such as the NTML, in 493 silico genome sequences, annotation databases, and theoretical metabolic stoichiometry but also 494 from our own experimental studies on mutant fitness, gene essentiality, and metabolite excretion 495 profile. The results presented in this work demonstrate the predictive capacity of the new 496 genome-scale metabolic reconstruction of S. aureus USA300_FPR3757, iSA840, in different 497 environments, utilizing different substrates, and with perturbed genetic contents, which paves the 498 way for a mechanistic understanding of S. aureus metabolism. This latest genome-scale model of 499 S. aureus demonstrates high performance in capturing gene essentiality, mutant phenotype and 500 substrate utilization behavior observed in experiments. However, the accuracy and prediction 501 capability, as well as the ability to generate model-based drug-target discoveries, can be further 502 enhanced by incorporating extensively vetted flux measurements, quantitative proteomics, and 503 kinetic measurements of metabolic intermediates. The development of a more accurate systems-504 level metabolic model for S. aureus will have a tremendous impact on future scientific 505 discoveries and will be a valuable resource shared among the staphylococcal research 506 23 community for the identification and implementation of intervention strategies that are 507 successful against a wide range of pathogenic strains. where each column represents a metabolite and each row signifies a particular reaction. In 520 addition to the mass balance constraints 61 , environmental constraints based on nutrient 521 availability, the relational constraint of reaction rates with concentrations of metabolites, and 522 thermodynamic constraints were imposed as necessary. The effects of gene expressions were 523 incorporated as regulatory constraints on the model as the cell adapted to change in media or 524 gene knockouts 62 . The non-growth-associated ATP maintenance demand was estimated to be 525 5.00 mmol/gDCW.hr in CDM media and 7.91 mmol/gDCW.hr in CDMG media in this study, 526 according to the established protocol 63 . 527 528 
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